Royal Bank of Canada’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Royal Bank of Canada’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-200	Closed	-$3K	–	6739
2014 Q4	$3K	Sell	200 -10,000	-98%	-$141K	﹤0.01%	5950
2014 Q3	$121K	Buy	+10,200	New	+$69.7K	﹤0.01%	4502
2013 Q4	–	Sell	-1,900	Closed	-$8K	–	6434
2013 Q3	$8K	Sell	1,900 -4,000	-68%	-$19K	﹤0.01%	5513
2013 Q2	$27K	Buy	+5,900	New	+$20.3K	﹤0.01%	4930

Royal Bank of Canada's AVNR Position: Q1 2015 in Review

Royal Bank of Canada sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 200 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in AVNR in Q2 2013 and held it in 4 quarters. The position peaked at $121K in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Royal Bank of Canada reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Royal Bank of Canada sold 200 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $3K.
Royal Bank of Canada first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 4 quarters.
Royal Bank of Canada's AVANIR PHARMACEUTICALS, INC CL A position peaked at $121K in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Royal Bank of Canada's 13F filing for Q1 2015, filed 15 May 2015.